Nemesis Bioscience today announced the successful completion of its latest funding round  bringing total seed funds raised to more than £700 000  and the commencement of its preclinical programmes The round was led by The Rainbow Seed Fund who co-invested alongside Finance Wales and Dr Mark McCamish